Press release
Phenylbutazone Market Plying for Significant Growth During 2017 - 2025
Phenylbutazone can be administered intravenously or orally (via powder, paste or feed-in). Phenylbutazone should not be injected in any place other than a vein and administered intramuscularly. Edema and tissue damage may also occur if the drug is injected repetitively into the same vein. Side effects of phenylbutazone include blood dyscrasia, GI ulcers, oral lesions, kidney damage and internal hemorrhage. Phenylbutazone should not be used in combination with vitamin K antagonists such as warfarin as it amplifies the anticoagulant effect of these drugs. Phenylbutazone displaces warfarin from toxic blood levels and plasma binding sites leading to haemorrhage.
Request Report For TOC @ https://www.persistencemarketresearch.com/toc/20644
The growth in end user industries is expected to increase demand for phenylbutazone. The growth in veterinary medicine industry is expected to increase consumption of phenylbutazone. In addition, rising demand for non steroidal anti-inflammatory drugs from emerging economies of Asia Pacific and Latin America is expected to boost demand for phenylbutazone. However, availability of substitutes and government regulations could hamper the growth of this market. Harpagophytum can replace phenylbutazone for treatment of fever and pain in horses.
Asia Pacific is expected to be the largest consumer of phenylbutazone followed by North America and Europe. China and India are the major consumers of phenylbutazone in Asia Pacific due to presence of established end user industries. Phenylbutazone manufacturers are shifting their base to emerging economies of Asia Pacific due to availability of government subsidies, land and cheap labor. Mongolia, Republic of Korea, Australia and New Zealand are expected to be other major consumers of phenylbutazone in Asia Pacific. North America and Europe are expected to experience moderate to high growth. In addition, demand for phenylbutazone is expected to increase in emerging economies of Latin America due to increasing demand for veterinary drugs. Argentina, Brazil, Colombia and Peru are major consumers of phenylbutazone in Latin America.
The market is dominated by large and medium chemical and pharmaceutical corporations. Some of the key players in this market are Santa Cruz Biotechnology, Inc. (U.S.), Hangzhou Hyper Chemicals Limited (China), Baoji Guokang Bio-Technology Co., Ltd.(China), Wuhan Yitongtai Science and Technology Co., Ltd. (China), Afine Chemicals Limited (china), Shanghai Win-Win Biochemical Co., Ltd. (china), Shaanxi TOP Pharm Chemical Co., Ltd.(China), Hangzhou Hyper Chemicals Limited (China), Hangzhou Ruijiang Chemical Co., Ltd. (China), Dalian Launcher Fine Chemical Co., Ltd.(China), Croma Life Science Pvt. Ltd (India), Swati Chemicals (India), Suchem Laboratories (India), Uni-med India (India), Afton Pharma (India) and Hefei TNJ Chemical Industry Co., Ltd. (China) among others. Companies are using strategic acquisitions and mergers to remain competitive in the market. In addition, companies are increasing their presence in emerging economies of Latin America and Europe to increase their market presence.
Request To Sample Of Report @ https://www.persistencemarketresearch.com/samples/20644
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Phenylbutazone Market Plying for Significant Growth During 2017 - 2025 here
News-ID: 924768 • Views: …
More Releases from Persistence Market Research
Home Healthcare Market to Reach US$954.0 Bn by 2033 at 7.8% CAGR - Persistence M …
The global home healthcare market is undergoing a structural transformation as healthcare systems pivot toward decentralized, patient-centric care delivery models. The market is projected to expand from US$ 580.8 billion in 2026 to US$ 954.0 billion by 2033, registering a robust CAGR of 7.8% during the forecast period. This growth trajectory builds upon a historical CAGR of 6.2% recorded between 2020 and 2025, reflecting sustained momentum across both developed and…
U.S. Assisted Reproductive Technology Market Growth at 5.1% CAGR Through 2033 - …
The U.S. assisted reproductive technology (ART) market is entering a period of sustained expansion, driven by rising infertility rates, shifting family planning patterns, and rapid technological innovation. The market is projected to grow from US$10.5 billion in 2026 to US$14.8 billion by 2033, registering a compound annual growth rate (CAGR) of 5.1% during the forecast period. Historically, the industry recorded a CAGR of 4.4% between 2020 and 2025, reflecting steady…
Autologous Cell Therapy Market to Reach US$15.4Bn by 2033 at 12.6% CAGR - Persis …
The global autologous cell therapy market is entering a transformative phase, driven by accelerating advancements in regenerative medicine, rising chronic disease prevalence, and a growing emphasis on personalized healthcare. According to current projections, the market is expected to reach US$6.7 billion in 2026 and expand significantly to US$15.4 billion by 2033, registering a robust CAGR of 12.6% during the forecast period. Historically, between 2020 and 2025, the market grew at…
Command Hooks Market Expands with Surge in Renter-Friendly and Drill-Free Home D …
The global command hooks market is projected to grow from US$ 3.0 billion in 2026 to US$ 5.3 billion by 2033, at a CAGR of 8.1%, reflecting rising consumer demand for easy-to-install, damage-free home organization products. As modern households increasingly prioritize convenience, aesthetics, and flexibility, command hooks have emerged as essential tools for both residential and commercial applications. Their ability to provide reliable adhesion without drilling holes or damaging walls…
More Releases for Phenylbutazone
Phenylbutazone Manufacturing Plant Project Report 2023: Industry Trends, Raw Mat …
IMARC Group's report titled "Phenylbutazone Manufacturing Plant Project Report 2023: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a comprehensive guide for establishing a phenylbutazone manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the…
Phenylbutazone Market – Notable Developments, Upcoming Trends & Future Applica …
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Global Phenylbutazone Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Phenylbutazone market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Phenylbutazone market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Phenylbutazone market, market definition, overview, industry opportunities and trends, investment strategy…
Phenylbutazone Market Region-wise Outlook of 2025 - Santa Cruz Biotechnology, In …
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Phenylbutazone Market is Expected to Witness Highest Growth During 2017 - 2025
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
Phenylbutazone Market Detailed Analysis and Forecast by 2025
Global Phenylbutazone Market: Snapshot
The phenylbutazone market has hit a road-block due to its disapproval from the country-wide market in the U.S. However, phenylbutazone, which are nonsteroidal anti-inflammatory drugs (NSAID) that are useful in treating pain, fever, menstrual cramps, arthritis, and other inflammations in human body, continue to be used in other parts of the World. Moreover, these drugs are also used by the veterinary department, wherein 23 actively marketed phenylbutazone…
